Ocular pain is also known as eye pain that occurs on the surface of the eye. Ocular pain is considered as a common medical condition that resolves on its own but, sometimes it creates emergency medical conditions. Possible causes for ocular pain includes corneal discomfort, pain in the sclera and discomfort in conjunctiva and pain in the iris. Moreover, few other etiology of ocular pain includes pain in extracellular muscle of the eye, burning sensation in nerves present in the eye and paining sensation on the eyelids. Sinusitis, migraines, traumatic events and glaucoma are considered as few of medical conditions that can cause ocular pain. possible signs and symptoms of ocular pain includes pain in the eye, partial loss of vision, light sensitivity, double vision, halos vision, severe headache, irregularly shaped pupil, bulging eye and blood inside the front of eye. Common test utilized for diagnosis of ocular pain includes slit-lamp exam, dilating drops test and tonometer test. Medications used for the treatment of ocular pain include antibacterial medications, antiviral medications and steroids.
This report aims to provide a comprehensive presentation of the global market for Ocular Pain, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ocular Pain. This report contains market size and forecasts of Ocular Pain in global, including the following market information:
Global Ocular Pain Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Ocular Pain market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Antibacterial Medications Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Ocular Pain include Sylentis, Ocular Therapeutix, Sun Pharmaceutical, Bayer, InSite Vision, Reata Pharmaceuticals, Kala Pharmaceuticals, Bristol Meyer Squibb and Merck, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Ocular Pain companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Ocular Pain Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Ocular Pain Market Segment Percentages, by Type, 2022 (%)
Antibacterial Medications
Antiviral Medications
Steroids
Global Ocular Pain Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Ocular Pain Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacy
Retail Pharmacy
Others
Global Ocular Pain Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Ocular Pain Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Ocular Pain revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Ocular Pain revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sylentis
Ocular Therapeutix
Sun Pharmaceutical
Bayer
InSite Vision
Reata Pharmaceuticals
Kala Pharmaceuticals
Bristol Meyer Squibb
Merck
Becton Dickinson
Outline of Major Chapters:
Chapter 1: Introduces the definition of Ocular Pain, market overview.
Chapter 2: Global Ocular Pain market size in revenue.
Chapter 3: Detailed analysis of Ocular Pain company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Ocular Pain in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Ocular Pain Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Ocular Pain Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Ocular Pain Overall Market Size
2.1 Global Ocular Pain Market Size: 2022 VS 2030
2.2 Global Ocular Pain Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Ocular Pain Players in Global Market
3.2 Top Global Ocular Pain Companies Ranked by Revenue
3.3 Global Ocular Pain Revenue by Companies
3.4 Top 3 and Top 5 Ocular Pain Companies in Global Market, by Revenue in 2022
3.5 Global Companies Ocular Pain Product Type
3.6 Tier 1, Tier 2 and Tier 3 Ocular Pain Players in Global Market
3.6.1 List of Global Tier 1 Ocular Pain Companies
3.6.2 List of Global Tier 2 and Tier 3 Ocular Pain Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Ocular Pain Market Size Markets, 2022 & 2030
4.1.2 Antibacterial Medications
4.1.3 Antiviral Medications
4.1.4 Steroids
4.2 By Type - Global Ocular Pain Revenue & Forecasts
4.2.1 By Type - Global Ocular Pain Revenue, 2018-2023
4.2.2 By Type - Global Ocular Pain Revenue, 2024-2030
4.2.3 By Type - Global Ocular Pain Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Ocular Pain Market Size, 2022 & 2030
5.1.2 Hospital Pharmacy
5.1.3 Retail Pharmacy
5.1.4 Others
5.2 By Application - Global Ocular Pain Revenue & Forecasts
5.2.1 By Application - Global Ocular Pain Revenue, 2018-2023
5.2.2 By Application - Global Ocular Pain Revenue, 2024-2030
5.2.3 By Application - Global Ocular Pain Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Ocular Pain Market Size, 2022 & 2030
6.2 By Region - Global Ocular Pain Revenue & Forecasts
6.2.1 By Region - Global Ocular Pain Revenue, 2018-2023
6.2.2 By Region - Global Ocular Pain Revenue, 2024-2030
6.2.3 By Region - Global Ocular Pain Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Ocular Pain Revenue, 2018-2030
6.3.2 US Ocular Pain Market Size, 2018-2030
6.3.3 Canada Ocular Pain Market Size, 2018-2030
6.3.4 Mexico Ocular Pain Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Ocular Pain Revenue, 2018-2030
6.4.2 Germany Ocular Pain Market Size, 2018-2030
6.4.3 France Ocular Pain Market Size, 2018-2030
6.4.4 U.K. Ocular Pain Market Size, 2018-2030
6.4.5 Italy Ocular Pain Market Size, 2018-2030
6.4.6 Russia Ocular Pain Market Size, 2018-2030
6.4.7 Nordic Countries Ocular Pain Market Size, 2018-2030
6.4.8 Benelux Ocular Pain Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Ocular Pain Revenue, 2018-2030
6.5.2 China Ocular Pain Market Size, 2018-2030
6.5.3 Japan Ocular Pain Market Size, 2018-2030
6.5.4 South Korea Ocular Pain Market Size, 2018-2030
6.5.5 Southeast Asia Ocular Pain Market Size, 2018-2030
6.5.6 India Ocular Pain Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Ocular Pain Revenue, 2018-2030
6.6.2 Brazil Ocular Pain Market Size, 2018-2030
6.6.3 Argentina Ocular Pain Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Ocular Pain Revenue, 2018-2030
6.7.2 Turkey Ocular Pain Market Size, 2018-2030
6.7.3 Israel Ocular Pain Market Size, 2018-2030
6.7.4 Saudi Arabia Ocular Pain Market Size, 2018-2030
6.7.5 UAE Ocular Pain Market Size, 2018-2030
7 Ocular Pain Companies Profiles
7.1 Sylentis
7.1.1 Sylentis Company Summary
7.1.2 Sylentis Business Overview
7.1.3 Sylentis Ocular Pain Major Product Offerings
7.1.4 Sylentis Ocular Pain Revenue in Global Market (2018-2023)
7.1.5 Sylentis Key News & Latest Developments
7.2 Ocular Therapeutix
7.2.1 Ocular Therapeutix Company Summary
7.2.2 Ocular Therapeutix Business Overview
7.2.3 Ocular Therapeutix Ocular Pain Major Product Offerings
7.2.4 Ocular Therapeutix Ocular Pain Revenue in Global Market (2018-2023)
7.2.5 Ocular Therapeutix Key News & Latest Developments
7.3 Sun Pharmaceutical
7.3.1 Sun Pharmaceutical Company Summary
7.3.2 Sun Pharmaceutical Business Overview
7.3.3 Sun Pharmaceutical Ocular Pain Major Product Offerings
7.3.4 Sun Pharmaceutical Ocular Pain Revenue in Global Market (2018-2023)
7.3.5 Sun Pharmaceutical Key News & Latest Developments
7.4 Bayer
7.4.1 Bayer Company Summary
7.4.2 Bayer Business Overview
7.4.3 Bayer Ocular Pain Major Product Offerings
7.4.4 Bayer Ocular Pain Revenue in Global Market (2018-2023)
7.4.5 Bayer Key News & Latest Developments
7.5 InSite Vision
7.5.1 InSite Vision Company Summary
7.5.2 InSite Vision Business Overview
7.5.3 InSite Vision Ocular Pain Major Product Offerings
7.5.4 InSite Vision Ocular Pain Revenue in Global Market (2018-2023)
7.5.5 InSite Vision Key News & Latest Developments
7.6 Reata Pharmaceuticals
7.6.1 Reata Pharmaceuticals Company Summary
7.6.2 Reata Pharmaceuticals Business Overview
7.6.3 Reata Pharmaceuticals Ocular Pain Major Product Offerings
7.6.4 Reata Pharmaceuticals Ocular Pain Revenue in Global Market (2018-2023)
7.6.5 Reata Pharmaceuticals Key News & Latest Developments
7.7 Kala Pharmaceuticals
7.7.1 Kala Pharmaceuticals Company Summary
7.7.2 Kala Pharmaceuticals Business Overview
7.7.3 Kala Pharmaceuticals Ocular Pain Major Product Offerings
7.7.4 Kala Pharmaceuticals Ocular Pain Revenue in Global Market (2018-2023)
7.7.5 Kala Pharmaceuticals Key News & Latest Developments
7.8 Bristol Meyer Squibb
7.8.1 Bristol Meyer Squibb Company Summary
7.8.2 Bristol Meyer Squibb Business Overview
7.8.3 Bristol Meyer Squibb Ocular Pain Major Product Offerings
7.8.4 Bristol Meyer Squibb Ocular Pain Revenue in Global Market (2018-2023)
7.8.5 Bristol Meyer Squibb Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Ocular Pain Major Product Offerings
7.9.4 Merck Ocular Pain Revenue in Global Market (2018-2023)
7.9.5 Merck Key News & Latest Developments
7.10 Becton Dickinson
7.10.1 Becton Dickinson Company Summary
7.10.2 Becton Dickinson Business Overview
7.10.3 Becton Dickinson Ocular Pain Major Product Offerings
7.10.4 Becton Dickinson Ocular Pain Revenue in Global Market (2018-2023)
7.10.5 Becton Dickinson Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Ocular Pain Market Opportunities & Trends in Global Market
Table 2. Ocular Pain Market Drivers in Global Market
Table 3. Ocular Pain Market Restraints in Global Market
Table 4. Key Players of Ocular Pain in Global Market
Table 5. Top Ocular Pain Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Ocular Pain Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Ocular Pain Revenue Share by Companies, 2018-2023
Table 8. Global Companies Ocular Pain Product Type
Table 9. List of Global Tier 1 Ocular Pain Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Ocular Pain Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Ocular Pain Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Ocular Pain Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Ocular Pain Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Ocular Pain Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Ocular Pain Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Ocular Pain Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Ocular Pain Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Ocular Pain Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Ocular Pain Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Ocular Pain Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Ocular Pain Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Ocular Pain Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Ocular Pain Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Ocular Pain Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Ocular Pain Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Ocular Pain Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Ocular Pain Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Ocular Pain Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Ocular Pain Revenue, (US$, Mn), 2024-2030
Table 30. Sylentis Company Summary
Table 31. Sylentis Ocular Pain Product Offerings
Table 32. Sylentis Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 33. Sylentis Key News & Latest Developments
Table 34. Ocular Therapeutix Company Summary
Table 35. Ocular Therapeutix Ocular Pain Product Offerings
Table 36. Ocular Therapeutix Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 37. Ocular Therapeutix Key News & Latest Developments
Table 38. Sun Pharmaceutical Company Summary
Table 39. Sun Pharmaceutical Ocular Pain Product Offerings
Table 40. Sun Pharmaceutical Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 41. Sun Pharmaceutical Key News & Latest Developments
Table 42. Bayer Company Summary
Table 43. Bayer Ocular Pain Product Offerings
Table 44. Bayer Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 45. Bayer Key News & Latest Developments
Table 46. InSite Vision Company Summary
Table 47. InSite Vision Ocular Pain Product Offerings
Table 48. InSite Vision Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 49. InSite Vision Key News & Latest Developments
Table 50. Reata Pharmaceuticals Company Summary
Table 51. Reata Pharmaceuticals Ocular Pain Product Offerings
Table 52. Reata Pharmaceuticals Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 53. Reata Pharmaceuticals Key News & Latest Developments
Table 54. Kala Pharmaceuticals Company Summary
Table 55. Kala Pharmaceuticals Ocular Pain Product Offerings
Table 56. Kala Pharmaceuticals Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 57. Kala Pharmaceuticals Key News & Latest Developments
Table 58. Bristol Meyer Squibb Company Summary
Table 59. Bristol Meyer Squibb Ocular Pain Product Offerings
Table 60. Bristol Meyer Squibb Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 61. Bristol Meyer Squibb Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Ocular Pain Product Offerings
Table 64. Merck Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Becton Dickinson Company Summary
Table 67. Becton Dickinson Ocular Pain Product Offerings
Table 68. Becton Dickinson Ocular Pain Revenue (US$, Mn) & (2018-2023)
Table 69. Becton Dickinson Key News & Latest Developments
List of Figures
Figure 1. Ocular Pain Segment by Type in 2022
Figure 2. Ocular Pain Segment by Application in 2022
Figure 3. Global Ocular Pain Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Ocular Pain Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Ocular Pain Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Ocular Pain Revenue in 2022
Figure 8. By Type - Global Ocular Pain Revenue Market Share, 2018-2030
Figure 9. By Application - Global Ocular Pain Revenue Market Share, 2018-2030
Figure 10. By Type - Global Ocular Pain Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Ocular Pain Revenue Market Share, 2018-2030
Figure 12. By Application - Global Ocular Pain Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Ocular Pain Revenue Market Share, 2018-2030
Figure 14. By Region - Global Ocular Pain Revenue Market Share, 2018-2030
Figure 15. By Country - North America Ocular Pain Revenue Market Share, 2018-2030
Figure 16. US Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Ocular Pain Revenue Market Share, 2018-2030
Figure 20. Germany Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 21. France Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Ocular Pain Revenue Market Share, 2018-2030
Figure 28. China Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 32. India Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Ocular Pain Revenue Market Share, 2018-2030
Figure 34. Brazil Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Ocular Pain Revenue Market Share, 2018-2030
Figure 37. Turkey Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Ocular Pain Revenue, (US$, Mn), 2018-2030
Figure 41. Sylentis Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Ocular Therapeutix Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Sun Pharmaceutical Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Bayer Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. InSite Vision Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Reata Pharmaceuticals Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Kala Pharmaceuticals Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Bristol Meyer Squibb Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Becton Dickinson Ocular Pain Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
